Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Impact of Vagus Nerve Stimulation on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study Report.
Journal: The Journal of clinical psychiatry
Published: July 14, 2026
Efficacy and Tolerability of Esketamine Augmented With Dextromethorphan/Bupropion for Treatment-Resistant Depression: A Case Series.
Journal: The Journal of clinical psychiatry
Published: November 05, 2025
Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report.
Journal: The international journal of neuropsychopharmacology
Published: October 21, 2025
The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus Statement.
Journal: Neuropsychiatric disease and treatment
Published: August 22, 2025
Rapid Onset and Sustained Efficacy of Onfasprodil (MIJ821), a Novel NR2B Negative Allosteric Modulator, in Patients With Treatment-Resistant Depression: A Phase 2, Randomized, Placebo-Controlled, Proof-of-Concept Study.
Journal: The Journal of clinical psychiatry
Published: August 06, 2025
Prognostic and Prescriptive Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial Report.
Journal: The Journal of clinical psychiatry
Published: July 17, 2025
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.
Journal: JAMA psychiatry
Published: July 02, 2025
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial.
Journal: Brain stimulation
Published: September 20, 2024
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trial.
Journal: Brain stimulation
Published: September 20, 2024
Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial report.
Journal: Journal of affective disorders
Published: June 25, 2024
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.
Journal: Brain stimulation
Published: January 04, 2024
Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series.
Journal: The Journal of clinical psychiatry
Published: February 01, 2023
Last Updated: 09/26/2026